Life SciencesPharmaceuticalsDrug Discovery

Global Ischemia Reperfusion Injury Market Size, Status and Forecast 2035

Lowest Prices Guaranteed Length Publisher Published Date SKU
from $3,300 139 Pages QYResearch Group April, 2018 QYR15651371
Lowest Prices Guaranteed
Price from $3,300
Length 139 Pages
Publisher QYResearch Group
Published Date April, 2018
SKU QYR15651371

Global Ischemia Reperfusion Injury Market Size, Status and Forecast 2035

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Ischemia Reperfusion Injury, provides comprehensive information on the therapeutics under development for Ischemia Reperfusion Injury (Cardiovascular), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The major players in global market include
Angion Biomedica
Catalyst Biosciences
Ischemix Inc
Opsona Therapeutics
Pharming
TheraSource
Bolder Biotechnology
Corline Biomedical
Mifcortx
Balmes Transplantation
NovelMed Therapeutics
Hope Pharmaceuticals
Omeros Corp
Prothix
SBI Pharmaceuticals

Geographically, this report split global into several key Regions, with, Revenue (M USD), market share and growth rate of Ischemia Reperfusion Injury for these regions, from 2025 to 2035 (forecast)
North America
Europe
China
Japan
Southeast Asia
India
RoW

On the basis on the end users/Application, this report covers
Heart Injury
Kidney Injury
Intestine Injury
Other Injury


1 Industry Overview
1.1 Ischemia Reperfusion Injury Market Overview
1.1.1 Ischemia Reperfusion Injury Product Scope
1.1.2 Market Status and Outlook
1.2 Global Ischemia Reperfusion Injury Market Size and Analysis by Regions (2025-2035)
1.2.1 North America Ischemia Reperfusion Injury Market Status and Outlook
1.2.2 Europe Ischemia Reperfusion Injury Market Status and Outlook
1.2.3 Japan Ischemia Reperfusion Injury Market Status and Outlook
1.2.4 China Ischemia Reperfusion Injury Market Status and Outlook
1.2.5 Southeast Asia Ischemia Reperfusion Injury Market Status and Outlook
1.2.6 India Ischemia Reperfusion Injury Market Status and Outlook
1.3 Ischemia Reperfusion Injury Market by Pipeline
1.3.1 Phase 2
1.3.2 Phase 1
1.3.3 Preclinical
1.3.4 Considerations for both Early and Late Phase Clinical Trials
1.3.5 Considerations for Early Phase Clinical Trials
1.3.6 Considerations for Late Phase Clinical Trials
2 Global Ischemia Reperfusion Injury Competition Analysis by Players
2.1 Global Ischemia Reperfusion Injury Products and Pipeline by Players
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 Manufacturers Ischemia Reperfusion Injury Headquarters and Established Date
2.2.4 The Technology Trends in Future
3 Analysis of Ischemia Reperfusion Injury Industry Key Manufacturers
3.1 Angion Biomedica
3.1.1 Company Profile
3.1.2 Product Information
3.1.3 Products and Pipeline
3.2 Catalyst Biosciences
3.2.1 Company Profile
3.2.2 Product Information
3.2.3 Products and Pipeline
3.3 Ischemix Inc
3.3.1 Company Profile
3.3.2 Product Information
3.3.3 Products and Pipeline
3.4 Opsona Therapeutics
3.4.1 Company Profile
3.4.2 Product Information
3.4.3 Products and Pipeline
3.5 Pharming
3.5.1 Company Profile
3.5.2 Product Information
3.5.3 Products and Pipeline
3.6 TheraSource
3.6.1 Company Profile
3.6.2 Product Information
3.6.3 Products and Pipeline
3.7 Bolder Biotechnology
3.7.1 Company Profile
3.7.2 Product Information
3.7.3 Products and Pipeline
3.8 Corline Biomedical
3.8.1 Company Profile
3.8.2 Product Information
3.8.3 Products and Pipeline
3.9 Mifcortx
3.9.1 Company Profile
3.9.2 Product Information
3.9.3 Products and Pipeline
3.10 Balmes Transplantation
3.10.1 Company Profile
3.10.2 Product Information
3.10.3 Products and Pipeline
3.11 NovelMed Therapeutics
3.11.1 Company Profile
3.11.2 Product Information
3.11.3 Products and Pipeline
3.12 Hope Pharmaceuticals
3.12.1 Company Profile
3.12.2 Product Information
3.12.3 Products and Pipeline
3.13 Omeros Corp
3.13.1 Company Profile
3.13.2 Product Information
3.13.3 Products and Pipeline
3.14 Prothix
3.14.1 Company Profile
3.14.2 Product Information
3.14.3 Products and Pipeline
3.15 SBI Pharmaceuticals
3.15.1 Company Profile
3.15.2 Product Information
3.15.3 Products and Pipeline
4 Global Ischemia Reperfusion Injury Market Size by Pipeline
4.1 Global Ischemia Reperfusion Injury Pipeline
4.2 Top Consumer of Ischemia Reperfusion Injury in Future
4.2.1 Sanofi
4.2.2 Novo Nordisk
4.2.3 Takeda
4.2.4 Eli Lilly
4.2.5 AstraZeneca
4.2.6 Novartis
4.2.7 Shire
4.2.8 AbbVie
4.2.9 Ipsene
4.2.10 Allergan
4.3 End Users of Ischemia Reperfusion Injury Treatment
5 North America Ischemia Reperfusion Injury Pipeline Introduction
5.1 BB3
5.2 Anti-C3: CB 2782
5.3 CMX-2043
5.4 rhMFG-E8
5.5 BBT-059
5.6 MIF-2
5.7 Monoclonal Antibodies (MoAbs)
5.8 Sodium Nitrite Injection
5.9 Omeros¡¯ MASP-3 Inhibitor Program
6 Europe Ischemia Reperfusion Injury Pipeline Introduction
6.1 OPN-305
6.2 RUCONEST
6.3 Renaparin
6.4 Delayed Graft Function in kindney Transplantation
6.5 PRO-02
7 Japan Ischemia Reperfusion Injury Pipeline Introduction
7.1 5-ALA
8 Rest of World Ischemia Reperfusion Injury Pipeline Introduction
9 Mechanism of Ischemia and Reperfusion
9.1 Symptom of Ischemia Reperfusion Injury
9.1.1 Ischemia and Reperfusion Causes Sterile Inflammation
9.1.2 Cell Death during Ischemia and Reperfusion
9.1.3 Microvascular Dysfunction
9.2 Therapeutic Approaches to Enhance Ischemia Tolerance
9.2.1 Ischemic Conditioning (Preconditioning, Post conditioning and Remote Conditioning)
9.2.2 Metabolic Strategies to Increase Ischemia Tolerance.
9.2.3 Therapeutic Gases
9.2.4 Nucleotide and Nucleoside Signaling
9.2.5 MicroRNAs (miRNAs) as Therapeutic Targets
10 Type of Ischemia and Reperfusion Injury
10.1 Single-organ Ischemia and Reperfusion
10.2 Multiple-organ Ischemia and Reperfusion
10.3 Ischemia and Reperfusion during Major Surgery
11 Market Forecast by Regions, Product and Application (2025-2035)
11.1 Global Ischemia Reperfusion Injury Market Size by Regions (2025-2035)
11.1.1 North America Ischemia Reperfusion Injury Revenue and Growth Rate (2025-2035)
11.1.2 Europe Ischemia Reperfusion Injury Revenue and Growth Rate (2025-2035)
11.1.3 China Ischemia Reperfusion Injury Revenue and Growth Rate (2025-2035)
11.1.4 Southeast Asia Ischemia Reperfusion Injury Revenue and Growth Rate (2025-2035)
11.1.5 India Ischemia Reperfusion Injury Revenue and Growth Rate (2025-2035)
11.1.6 Japan Ischemia Reperfusion Injury Revenue and Growth Rate (2025-2035)
11.2 Global Ischemia Reperfusion Injury Market Size by Application (2025-2035)
12 Ischemia Reperfusion Injury Market Dynamics
12.1 Ischemia Reperfusion Injury Market Opportunities
12.2 Ischemia Reperfusion Injury Challenge and Risk
12.2.1 Clinical Phase Costs
12.2.2 Capitalized Costs
12.2.3 Downside Risks of Economy
12.3 Marketing Strategy Analysis, Distributors
12.3.1 Marketing Channel
12.3.2 Market Positioning
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 External Environmental Change
14 Research Findings and Conclusion
15 Methodology and Data Source
15.1 Methodology/Research Approach
15.1.1 Research Programs/Design
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Disclaimer
15.4 Author List
List of Tables and Figures
Figure the Ischemia Reperfusion Injury Example
Figure Global Ischemia Reperfusion Injury Market Size (M USD) Status and Outlook (2025-2035)
Table Global Market Ischemia Reperfusion Injury Revenue (M USD) Comparison by Regions 2025-2035
Figure Global Ischemia Reperfusion Injury Market Share by Regions (2025-2035)
Figure North America Ischemia Reperfusion Injury Market Size (M USD) and Growth Rate (2025-2035)
Figure Europe Ischemia Reperfusion Injury Market Size (M USD) and Growth Rate (2025-2035)
Figure Japan Ischemia Reperfusion Injury Market Size (M USD) and Growth Rate (2025-2035)
Figure China Ischemia Reperfusion Injury Market Size (M USD) and Growth Rate (2025-2035)
Figure Southeast Asia Ischemia Reperfusion Injury Market Size (M USD) and Growth Rate (2025-2035)
Figure India Ischemia Reperfusion Injury Market Size (M USD) and Growth Rate (2025-2035)
Figure Global Ischemia Reperfusion Injury Market Share by Pipeline in 2017
Table Ischemia Reperfusion Injury on Phase 2
Table Ischemia Reperfusion Injury on Phase 1
Table Ischemia Reperfusion Injury on Preclinical
Table Global Ischemia Reperfusion Injury Products and Pipeline by Players
Figure Global Ischemia Reperfusion Injury Pipeline by Players in 2017
Table Product Brands of Major Manufacturers
Table Manufacturers Ischemia Reperfusion Injury Headquarters and Established Date
Table Angion Biomedica Company Profile
Figure Ischemia Reperfusion Injury Product Introduction of Angion Biomedica
Table Products and Pipeline of Angion Biomedica
Table Catalyst Biosciences Company Profile
Figure Ischemia Reperfusion Injury Product Introduction of Catalyst Biosciences
Table Products and Pipeline of Catalyst Biosciences
Table Ischemix Inc Company Profile
Figure The Molecular Structure of CMX-2043
Table Products and Pipeline of Ischemix Inc
Table Opsona Therapeutics Company Profile
Table Products and Pipeline of Opsona Therapeutics
Table Pharming Company Profile
Figure Ischemia Reperfusion Injury Product Introduction of Pharming
Table Products and Pipeline of Pharming
Table TheraSource Company Profile
Table Products and Pipeline of TheraSource
Table Bolder Biotechnology Company Profile
Figure Ischemia Reperfusion Injury Product Picture and Specifications of Bolder Biotechnology
Table Products and Pipeline of Bolder Biotechnology
Table Corline Biomedical Company Profile
Table Products and Pipeline of Corline Biomedical
Table Mifcortx Company Profile
Figure Ischemia Reperfusion Injury Product Picture and Specifications of Mifcortx
Table Products and Pipeline of Mifcortx
Table Balmes Transplantation Company Profile
Figure Ischemia Reperfusion Injury Product Picture and Specifications of Balmes Transplantation
Table Products and Pipeline of Balmes Transplantation
Table NovelMed Therapeutics Company Profile
Figure Ischemia Reperfusion Injury Product Picture of NovelMed Therapeutics
Table Products and Pipeline of NovelMed Therapeutics
Table Hope Pharmaceuticals Company Profile
Table Products and Pipeline of Hope Pharmaceuticals
Table Omeros Corp Company Profile
Table Products and Pipeline of Omeros Corp
Table Prothix Company Profile
Table Products and Pipeline of Prothix
Table SBI Pharmaceuticals Company Profile
Table Products and Pipeline of SBI Pharmaceuticals
Table Ischemia Reperfusion Injury on Phase 2
Table Ischemia Reperfusion Injury on Phase 1
Table Ischemia Reperfusion Injury on Preclinical
Figure Global Ischemia Reperfusion Injury by Pipeline in 2017
Table Sanofi Company Profile
Table Novo Nordisk Company Profile
Table Takeda Company Profile
Table Eli Lilly Company Profile
Table AstraZeneca Company Profile
Table Novartis Company Profile
Table Shire Company Profile
Table AbbVie Company Profile
Table Ipsen Company Profile
Table Allergan Company Profile
Table Top Consumer / End Users of Ischemia Reperfusion Injury
Figure Ischemia Reperfusion Injury Product Introduction of Angion Biomedica
Figure Ischemia Reperfusion Injury Product Introduction of Catalyst Biosciences
Figure The Molecular Structure of CMX-2043
Figure Ischemia Reperfusion Injury Product Picture and Specifications of Bolder Biotechnology
Figure Ischemia Reperfusion Injury Product Picture and Specifications of Mifcortx
Figure Ischemia Reperfusion Injury Product Picture of NovelMed Therapeutics
Figure Ischemia Reperfusion Injury Product Introduction of Pharming
Figure Ischemia Reperfusion Injury Product Picture and Specifications of Balmes Transplantation
Figure Biological Processes Implicated in Ischemia and Reperfusion
Figure Therapeutic Gases for the Treatment of Ischemia and Reperfusion.
Figure Nucleotide and Nucleoside Signaling during Ischemia and Reperfusion
Figure MiRNA Pathways Implicated in Myocardial Ischemia and Reperfusion
Table Examples of Ischemia and Reperfusion Injury
Figure Cold Ischemia Time Thresholds in Solid Organ Allografts
Figure Global Ischemia Reperfusion Injury Market Size (M USD) and Growth Rate (2025-2035)
Table Global Ischemia Reperfusion Injury Market Size (M USD) by Regions (2025-2030)
Table Global Ischemia Reperfusion Injury Market Size (M USD) by Regions (2030-2035)
Figure Global Ischemia Reperfusion Injury Market Size Share by Regions (2025-2035)
Figure Global Ischemia Reperfusion Injury Market Size Share by Regions in 2035
Figure North America Ischemia Reperfusion Injury Revenue (M USD) and Growth Rate (2025-2035)
Figure Europe Ischemia Reperfusion Injury Revenue (M USD) and Growth Rate (2025-2035)
Figure China Ischemia Reperfusion Injury Revenue (M USD) and Growth Rate (2025-2035)
Figure Southeast Asia Ischemia Reperfusion Injury Revenue (M USD) and Growth Rate (2025-2035)
Figure India Ischemia Reperfusion Injury Revenue (M USD) and Growth Rate (2025-2035)
Figure Japan Ischemia Reperfusion Injury Revenue (M USD) and Growth Rate (2025-2035)
Table Global Ischemia Reperfusion Injury Market Size (M USD) by Application (2025-2030)
Table Global Ischemia Reperfusion Injury Market Size (M USD) by Application (2030-2035)
Figure Global Ischemia Reperfusion Injury Market Size by Application (2025-2035)
Figure Global Ischemia Reperfusion Injury Market Size by Application in 2035
Figure typical phases from research to the market for a drug candidate
Table Out-of-pocket Preclinical and Clinical Period Cost per Investigational Biopharmaceutical Compound
Table Capitalized Preclinical and Clinical Period costs per Investigational Biopharmaceutical Compound
Figure Global GDP Growth Rate for 2016
Figure Real GDP Growth 2016-2020 annual Average
Figure Marketing Channel for Biopharmaceuticals
Figure Global Activity in Organ Transplantation
Figure US GDP 2006-2016 (Billion USD)
Figure US CPI Change 2017-2018
Figure EU GDP 2006-2016 (Billion USD)
Figure EU CPI Change 2012-2016
Figure Germany GDP 2006-2016 (Billion USD)
Figure Germany CPI Change 2017-2018
Figure UK GDP 2006-2016 (Billion USD)
Figure UK CPI Change 2017-2018
Figure Italy GDP 2006-2016 (Billion USD)
Figure Italy CPI Change 2017-2018
Figure Japan GDP 2006-2016 (Billion USD)
Figure Japan CPI Change 2012-2016
Figure China GDP 2006-2016 (Billion USD)
Figure China CPI Change 2017-2018
Table Research Programs/Design for This Report

$3,300
$6,600
 
Research assistance
US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks